{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:24:39Z","timestamp":1761863079146,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ando.2007.02.003","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T18:07:45Z","timestamp":1329934065000},"page":"349-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["11\u03b2-hydroxyst\u00e9ro\u00efde d\u00e9shydrog\u00e9nases. Avanc\u00e9es r\u00e9centes"],"prefix":"10.1016","volume":"68","author":[{"given":"M.-C.","family":"Vantyghem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marcelli-Tourvieille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Defrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Wemeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2007.02.003_bib1","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2337\/db06-0601","article-title":"Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11\u00df hydroxysteroid dehydrogenase type 1 activity","volume":"55","author":"Basu","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2007.02.003_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1081\/ERC-120016822","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol","volume":"28","author":"Bujalska","year":"2002","journal-title":"Endocr. Res."},{"key":"10.1016\/j.ando.2007.02.003_bib3","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(96)11222-8","article-title":"Does central obesity reflect \"Cushing's disease of the omentum\"?","volume":"349","author":"Bujalska","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.02.003_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/JPEM.2000.13.3.253","article-title":"Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome","volume":"13","author":"Chin","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(00)00344-6","article-title":"Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone","volume":"27","author":"Cooper","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.ando.2007.02.003_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2265.2006.02547.x","article-title":"Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome","volume":"65","author":"Draper","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.02.003_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.1.06019","article-title":"11beta-hydroxysteroid dehydrogenase and the prereceptor regulation of corticosteroid hormone action","volume":"186","author":"Draper","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ando.2007.02.003_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1214","article-title":"Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency","volume":"34","author":"Draper","year":"2003","journal-title":"Nat. Genet."},{"issue":"8618","key":"10.1016\/j.ando.2007.02.003_bib9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.02.003_bib10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199110243251709","article-title":"Lessons from licorice","volume":"325","author":"Edwards","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.02.003_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0140-6736(93)90148-A","article-title":"Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?","volume":"341","author":"Edwards","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.02.003_bib12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM199110243251706","article-title":"Licorice-induced hypermineralocorticoidism","volume":"325","author":"Farese","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.02.003_bib13","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0303-7207(96)03787-2","article-title":"Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess","volume":"119","author":"Ferrari","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ando.2007.02.003_bib15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/jc.2005-2222","article-title":"Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome","volume":"91","author":"Gambineri","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ando.2007.02.003_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2006.02552.x","article-title":"Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women","volume":"65","author":"Goedecke","year":"2006","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.02.003_bib17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/jcem-21-10-1231","article-title":"The influence of thyroid hormone on hydrocortisone production andmetabolism","volume":"21","author":"Hellman","year":"1961","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-2007-1003757","article-title":"Are the hypokalaemia and hypertension in Cushing's disease caused by apparent mineralocorticoid excess?","volume":"23","author":"Hermus","year":"1991","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ando.2007.02.003_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2004-814570","article-title":"Hypothalamic regulation of adiposity: the role of 11 \u00df hydroxysteroid dehydrogenase type 1","volume":"36","author":"Hochberg","year":"2006","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ando.2007.02.003_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2005.12.002","article-title":"The role of 11 \u00df hydroxysteroid dehydrogenases in the brain","volume":"248","author":"Holmes","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ando.2007.02.003_bib21","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/oby.2006.175","article-title":"Hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance","volume":"14","author":"Koska","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ando.2007.02.003_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1530\/eje.0.1460553","article-title":"Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy","volume":"146","author":"Lavery","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ando.2007.02.003_bib23","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1074\/jbc.M512635200","article-title":"Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation","volume":"281","author":"Lavery","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ando.2007.02.003_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2004-825724","article-title":"Impairment of the antiproliferative effect of glucocortico\u00efds by 11 \u00df hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cells","volume":"36","author":"Lipka","year":"2004","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ando.2007.02.003_bib25","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jcem-70-6-1637","article-title":"The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers","volume":"70","author":"MacKenzie","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0960-0760(92)90077-V","article-title":"Glucocorticoid-dependant hypertension","volume":"43","author":"Mantero","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ando.2007.02.003_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1995.tb01923.x","article-title":"Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of \"apparent\" mineralocorticoid excess","volume":"43","author":"Milford","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.02.003_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s004670000377","article-title":"Nephrocalcinosis and renal cysts associated with apparent mineralocorticoid excess syndrome","volume":"15","author":"Moudgil","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ando.2007.02.003_bib29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ando.2007.02.003_bib30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.HYP.27.6.1193","article-title":"Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype","volume":"27","author":"Mune","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2007.02.003_bib31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/en.2005-0544","article-title":"Inhibition of 11 \u00df hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells","volume":"147","author":"Nigawara","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2007.02.003_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1210\/en.2006-0603","article-title":"Liverselective transgene rescue of hypothalamic-pituitary adrenal axis dysfunction in 11 \u00df hydroxysteroid dehydrogenase type 1 deficient mice","volume":"148","author":"Paterson","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2007.02.003_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2003.10.019","article-title":"Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population","volume":"217","author":"Quinkler","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ando.2007.02.003_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/eje.1.01954","article-title":"Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function","volume":"153","author":"Quinkler","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ando.2007.02.003_bib35","first-page":"2037","article-title":"Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye","volume":"42","author":"Rauz","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ando.2007.02.003_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1056\/NEJM199402173300703","article-title":"Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase","volume":"330","author":"Rodin","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ando.2007.02.003_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0960-0760(93)90132-G","article-title":"Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research","volume":"45","author":"Shackleton","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ando.2007.02.003_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2006-1349","article-title":"Lack of Association of the 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Gene 83,557insA and Hexose-6-Phosphate Dehydrogenase Gene R453Q Polymorphisms with Body Composition, Adrenal Androgen Production, Blood Pressure, Glucose Metabolism and Dementia","volume":"92","author":"Smit","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age","volume":"2","author":"Stewart","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.02.003_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/cs0780049","article-title":"Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man","volume":"78","author":"Stewart","year":"1990","journal-title":"Clin. Sci. (Lond.)"},{"issue":"335","key":"10.1016\/j.ando.2007.02.003_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(90)90664-Q","article-title":"5 alpha-reductase activity in polycystic ovary syndrome","volume":"24","author":"Stewart","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2007.02.003_bib42","first-page":"748","article-title":"11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease","volume":"76","author":"Stewart","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0960-0760(99)00072-2","article-title":"Cortisol as a mineralocorticoid in human disease","volume":"69","author":"Stewart","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ando.2007.02.003_bib44","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1210\/jc.2002-020687","article-title":"Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity","volume":"87","author":"Tomlinson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib45","first-page":"89","article-title":"Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids","volume":"102S","author":"Taylor","year":"1984","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ando.2007.02.003_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000184274","article-title":"Alcohol inhibits 11-beta-hydroxysteroid dehydrogenase activity in rat kidney and liver","volume":"43","author":"Valentino","year":"1995","journal-title":"Horm. Res."},{"key":"10.1016\/j.ando.2007.02.003_bib47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","article-title":"A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol","volume":"49","author":"Ulick","year":"1979","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib48","first-page":"963","article-title":"Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome","volume":"74","author":"Ulick","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib49","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1210\/jc.2004-0113","article-title":"Glucocorticoids stimulate the expression of 11 \u00df hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells","volume":"89","author":"Van Beek","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF03347306","article-title":"Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: overt and subclinical hypothyroidism","volume":"21","author":"Vantyghem","year":"1998","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ando.2007.02.003_bib51","first-page":"271","article-title":"11 beta-Hydroxysteroid dehydrogenase (11-beta-OHSD): physiology and lack of action in pathology","volume":"55","author":"Vantyghem","year":"1994","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.ando.2007.02.003_bib52","first-page":"160","article-title":"Impaired conversion of cortisol to cortisone in chronic renal insufficiency--a cause of hypertension or an epiphenomenon?","volume":"125","author":"Vierhapper","year":"1991","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ando.2007.02.003_bib53","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2006-0819","article-title":"Acute in vivo regulation of 11{beta}-hydroxysteroid dehydrogenase type 1 activity by insulin and Intralipid infusions in humans","volume":"91","author":"Wake","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.1992.tb01478.x","article-title":"Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome","volume":"37","author":"Walker","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.02.003_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1993.tb01778.x","article-title":"Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension","volume":"39","author":"Walker","year":"1993","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.02.003_bib56","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1210\/jc.2005-0942","article-title":"Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample","volume":"90","author":"White","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib57","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1523-1755.2005.67119.x","article-title":"Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides","volume":"67","author":"Williams","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ando.2007.02.003_bib58","first-page":"3145","article-title":"Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.02.003_bib59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2003.12.019","article-title":"Expression of 11 \u00df hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer","volume":"210","author":"Zbankova","year":"2004","journal-title":"Cancer Lett."}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342660700039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342660700039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:42:01Z","timestamp":1757716921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342660700039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S000342660700039X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2007.02.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"11\u03b2-hydroxyst\u00e9ro\u00efde d\u00e9shydrog\u00e9nases. Avanc\u00e9es r\u00e9centes","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2007.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}